Supplementary Materials and Methods, Tables 1-2 and Figure Legends from Pharmacodynamic and Antineoplastic Activity of BI 836845, a Fully Human IGF Ligand-Neutralizing Antibody, and Mechanistic Rationale for Combination with Rapamycin
Katrin Friedbichler(Boehringer Ingelheim (Germany)), Paul J. Adam(Boehringer Ingelheim (Austria))
Cited by 0